Clinical Trial Update: Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the cognitive effects of Seroquel immediate-release versus extended-release in patients with stable schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)
• Seroquel IR (quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2012-07-27